Dexamethasone and Salbutamol Stimulate Human Lung Fibroblast Proliferation

World Allergy Organization Journal

Francesca Levi-Schaffer⁴  Neville Berkman¹  Uzi Izhar³  Dan Admon²  Eran Pickholtz⁴ 

[1] Institute of Pulmonology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel;The Heart Institute;Department of Cardiothoracic Surgery, Jerusalem, Israel;Department of Pharmacology, Institute for Drug Research, School of Pharmacy, The Hebrew University of Jerusalem, P.O. Box 12065, Jerusalem 91120, Israel

关键词: IL-6;    salbutamol;    dexamethasone;    proliferation;    lung;    fibroblasts;   

Others  :  1137718
DOI  :  10.1097/WOX.0b013e31821d1186

【 授权许可】

   
2011 World Allergy Organization; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Davies DE, Wicks J, Powell RM, Puddicombe SM, Holgate ST, et al.: Airway remodeling in asthma: new insights. J Allergy Clin Immunol 2003, 111:215-225.
• [2]Homer RJ, Elias JA: Airway remodeling in asthma: therapeutic implications of mechanisms. Physiology (Bethesda) 2005, 20:28-35.
• [3]Al-Muhsen S, Johnson JR, Hamid GL: Remodeling in asthma. J Allergy Clin Immunol 2011, 128:451-462. quiz 463-464
• [4]Lewis CC, Chu HW, Westcott JY, Tucker A, Langmack EL, et al.: Airway fibroblasts exhibit a synthetic phenotype in severe asthma. J Allergy Clin Immunol 2005, 115:534-540.
• [5]Okayama Y, Ra C, Saito H: Role of mast cells in airway remodeling. Curr Opin Immunol 2007, 19:687-693.
• [6]Minshall EM, Leung DY, Martin RJ, Song YL, Cameron L, et al.: Eosinophil-associated TGF-beta1 mRNA expression and airway fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 1997, 17:326-333.
• [7]Garbuzenko E, Berkman N, Puxeddu I, Kramer M, Nagler A, Levi-Schaffer F: Mast cells induce activation of human lung fibroblasts in vitro. Exp Lung Res 2004, 30:705-721.
• [8]Puxeddu I, Bader R, Piliponsky AM, Reich R, Levi-Schaffer F, Berkman N: The CC chemokine eotaxin/CCL11 has a selective profibrogenic effect on human lung fibroblasts. J Allergy Clin Immunol 2006, 117:103-110.
• [9]Micera A, Vigneti E, Pickholtz D, Reich R, Pappo O, et al.: Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts demonstrating a direct role for this factor in tissue repair. Proc Natl Acad Sci USA 2001, 98:6162-6167.
• [10]Sommerhoff CP: Mast cell tryptases and airway remodeling. Am J Respir Crit Care Med 2001, 164:S52-S58.
• [11]Warshamana GS, Martinez S, Lasky JA, Corti M, Brody AR: Dexamethasone activates expression of the PDGF-alpha receptor and induces lung fibroblast proliferation. Am J Physiol 1998, 274:L499-L507.
• [12]Wen FQ, Kohyama T, Skold CM, Zhu YK, Liu X, et al.: Glucocorticoids modulate TGF-beta production by human fetal lung fibroblasts. Inflammation 2003, 27:9-19.
• [13]Da Silva CA, Kassel O, Lebouquin R, Lacroix EJ, Frossard N: Paradoxical early glucocorticoid induction of stem cell factor (SCF) expression in inflammatory conditions. Br J Pharmacol 2004, 141:75-84.
• [14]Fouty B, Moss T, Solodushko V, Kraft M: Dexamethasone can stimulate G1-S phase transition in human airway fibroblasts in asthma. Eur Respir J 2006, 27:1160-1167.
• [15]Sabatini F, Silvestri M, Sale R, Serpero L, Giuliani M, et al.: Concentration-dependent effects of mometasone furoate and dexamethasone on foetal lung fibroblast functions involved in airway inflammation and remodeling. Pulm Pharmacol Ther 2003, 16:287-297.
• [16]Olivieri D, Chetta A, Del Donno M: Effect of short term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo controlled study. Am J Respir Crit Care Med 1997, 155:1864-1871.
• [17]Sont JK, Willems LN, Bel EH, van Krieken JH, Vandenbroucke JP, et al.: Clinical control and histopathological outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. Am J Respir Crit Care Med 1999, 159:1043-1051.
• [18]Lundgren R, Soderberg M, Horstedt P, Stenling R: Morphological studies of bronchial biopsies from asthmatics before and after ten years of treatment with inhaled steroids. Eur Respir J 1988, 1:883-889.
• [19]Descalzi D, Folli C, Nicolini G, Riccio AM, Gamalero C, Scordamaglia F, Canonica GW: Anti-proliferative and anti-remodelling effect of beclomethasone dipropionate, formoterol and salbutamol alone or in combination in primary human bronchial fibroblasts. Allergy 2008, 63:432-437.
• [20]Silvestri M, Fregonese L, Sabatini F, Dasic G, Rossi GA: Fluticasone and salmeterol downregulate in vitro, fibroblast proliferation and ICAM-1 or H-CAM expression. Eur Respir J 2001, 18:139-145.
• [21]Butterfield JH, Weiler DA: In vitro sensitivity of immature human mast cells to chemotherapeutic agents. Int Arch Allergy Appl Immunol 1989, 89:297-300.
• [22]Berkman N, Levi-Schaffer F: Profibrotic and angiogenic factors in asthma. In Inflammation and Allergy Drug Design. 1st edition. Edited by Izuhara K, Holgate ST, Wills-Karp M. Oxford, UK: Wiley-Blackwell Publishing Ltd; 2011:237-252.
• [23]Chalaris A, Garbers C, Rabe B, Rose-John S, Scheller J: The soluble interleukin 6 receptor: generation and role in inflammation and cancer. Eur J Cell Biol 2011, 90:484-494.
• [24]Rose-John S, Waetzig GH, Scheller J, Grotzinger J, Seegert D: The IL-6/sIL-6R complex as a novel target for therapeutic approaches. Expert Opin Ther Targets 2007, 11:613-624.
• [25]Hogaboam C, Kunkel SL, Strieter RM, Taub DD, Lincoln P, Standiford TY, Lukacs NK: Novel role of transmembrane SCF for mast cell activation and eotaxin production in mast cell-fibroblast interactions. J Immunol 1998, 160:6166-6171.
• [26]Pujols L, Fuentes-Prado M, Fernández-Bertolín L, Alobid I, Roca-Ferrer J, Mullol J, Picado C: Lower sensitivity of nasal polyp fibroblasts to glucocorticoid anti-proliferative effects. Respir Med 2011, 105:218-225.
• [27]Suzuki T, Arakawa H, Mizuno T, Muramatsu K, Tadaki H, et al.: Differential regulation of eotaxin expression by dexamethasone in normal human lung fibroblasts. Am J Respir Cell Mol Biol 2008, 38:707-714.
• [28]Futamura K, Orihara K, Hashimoto N, Morita H, Fukuda S, et al.: Beta2-adrenoceptor agonists enhance cytokine-induced release of thymic stromal lymphopoietin by lung tissue cells. Int Arch Allergy Immunol 2010, 152:353-361.
• [29]Zitnik RH, Khiting NL, Elias JA: Glucocorticoid inhibition of interleukin-1 induced interleukin-6 production by human lung fibroblasts: evidence for transcriptional and post-transcriptional regulatory mechanisms. Am J Respir Cell Mol Biol 1994, 10:643-650.
• [30]Agarwal D, Glasel JA: Differential effects of opioid and adrenergic agonists on proliferation in a cultured cell line. Cell Prolif 1999, 32:215-229.
• [31]Dammeier J, Beer HD, Brauchle M, Werner S: Dexamethasone is a novel potent inducer of connective tissue growth factor expression. Implications for glucocorticoid therapy. J Biol Chem 1998, 273:18185-18190.
• [32]Yang JQ, Rüdiger JJ, Hughes JM, Goulet S, Gencay-Cornelson MM, et al.: Cell density and serum exposure modify the function of the glucocorticoid receptor C/EBP complex. Am J Respir Cell Mol Biol 2008, 38:414-422.
• [33]Peters MJ, Adock IM, Brown CR, Barnes PG: Beta adrenoceptor agonists interfere with glucocorticoid receptor DNA binding in rat lung. Eur J Pharmacol 1995, 289:275-281.
• [34]Eickelberg O, Roth M, Lörx R, Bruce V, Rüdiger J, Johnson M, Block LH: Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells. J Biol Chem 1999, 274:1005-1010.